Email Us
View Reports

Apheresis Market

Apheresis Market - By Product (Devices, Disposables, Interventional/Surgical Simulators), By Apheresis Procedure (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Other Apheresis Procedures), By Technology ( Centrifugation, Membrane Separation), By Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Size, Share, Growth and Global Forecast to 2025

  • ID : 88395082  |  
  • Published : Feb-2019  |  
  • Region : Global  |  
  • Pages : 140   |  
  • Publisher : Mordor Intelligence

Apheresis Market Size and Growth Rate:

According to the Research Report, the Global Apheresis Market Size was valued at USD 1.7 Billion in 2018 and was Expected to Reach USD 3.9 Billion by 2025 at a CAGR of 9.5% during the forecast period 2018-2025.

Apheresis Market Overview:

The propelling factors for the growth of the apheresis market include the increasing number of disease burden, a rise in demand for blood components and associated safety, technological advancement in the development of new apheresis techniques and rise in the reimbursement policies and funding for apheresis procedures is expected to experience a boost in the forecast period.

With the increasing number of surgeries and surgical techniques, advanced treatments have led to global demand for the blood and the blood components. The need for blood components is significantly growing and contributing to health care spending. Apheresis has also recently witnessed a high demand due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Therefore, apheresis technology is used to reduce the number of white cells, until other medications can control them. With the steady increase in the number of patients suffering from these diseases, ailments, and the technical ease of using these devices in the treatment of these diseases, requiring a minimal hospital stay, the global apheresis market is poised to grow during the forecast period.

The use of apheresis in clinically ill patients is increasing day by day, and it has been widely used as primary therapy or as an adjunct to other treatments for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure.

Therefore with the steady increase in the number of patients suffering from these diseases, ailments, and the technical ease of using these devices in the treatment of these diseases, requiring a minimal hospital stay, the global apheresis market is poised to grow during the forecast period.

The Scope of the Apheresis Market Report:

As per the scope of the report, apheresis is a medical technique where the blood of an individual, be a donor or a patient, is passed through an apparatus that segregates out a particular constituent and returns the rest to the blood circulation. It involves blood purification and blood component separation by using centrifugation or membrane filtration technology. This procedure is performed for blood donation component or for the treatment of disease.

Asia-Pacific holds the Fastest Growth and is Expected to follow the Same Trend over the Forecast Period

The Asia Pacific is predicted to witness high growth, owing to the rising geriatric population and the increasing prevalence of several choric diseases. China is found to be one of the largest consumers and manufacturers in the global plasma-derived products market and serves a vast population. Great progress has been made in the Chinese plasma fractionation industry in the past 50 years. Moreover, increasing healthcare expenditure is another critical factor that is likely to enhance the growth of the market in the near future.

Some of the Prominent Companies leading the Global Apheresis Market Profiled in the Report are:

  • Asahi Kasei Corporation
  • b. braun melsungen ag
  • Cerus Corporation
  • Fresenius Kabi AG,
  • Haemonetics Corporation
  • Medica S.p.A.
  • Therakos, Inc.
  •  Kawasumi Laboratories Inc
  • Terumo Corporation,

The Research Report segments the Global Blood Apheresis Market into the following submarkets:

Global Apheresis Market -By Product:

  • Devices
  • Disposables
  • Interventional/Surgical Simulators

Global Apheresis Market - By Apheresis Procedure:

  • Leukapheresis
  • Plasmapheresis
  • Plateletpheresis
  • Erythrocytapheresis
  • Other Apheresis Procedures

Global Apheresis Market - By Technology:

  • Centrifugation
  • Membrane Separation

Global Apheresis Market - By Application:

  • Renal Disorders
  • Hematological Disorders
  • Neurological Disorders
  • Autoimmune Disorders
  • Other Applications

Apheresis Market – By Region:

  • North America

    •  US
    •  Canada
    •  Mexico

  • Europe

    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe

  • Asia Pacific

    • Japan
    • Australia
    • South Korea
    • China
    • Rest of Asia-Pacific

  • The Middle East and Africa

    • GCC
    • South Africa
    • Rest of The Middle East and Africa

  • Latin America

    • Brazil
    • Argentina
    • Rest of Latin America

Competitive Landscape of Apheresis Market:

The market studied is dominated by a few major players, and currently, the market is well established in many areas and has shown nascent success history. However, its full potential is yet to be determined in the developing regions. With increasing government initiatives, there is an awareness among people, which is further driving the growth of the market studied.

Key Market Trends for Apheresis Market:

Hematological Disorders is the Segment under Application that is Expected to Grow Fastest during the Forecast Period.

Hematological disorders are found common in low-income countries, and they make a substantial contribution to morbidity and mortality of individuals in these regions and harm the growth. Hence, owing to the increasing burden of hematological incidences and growing applications of apheresis as a treatment method for hematological disorders, the market for apheresis for hematological disorders would grow in the forecast period.

The recent years brought about a rise in new options of therapeutic apheresis, such as Immunoadsorption, double filtration, and cytapheresis used in the treatment of both primary and secondary autoimmune renal diseases. Those methods, more selective and safer than the classic TA, are potentially more efficient in the removal of pathogens, thus reducing the intoxication of the patient's organism.


1. Study Deliverables

2. Study Assumptions

3. The scope of the Study




1. APHERESIS Market Overview

2. Market Drivers

1. Increasing Global Disease Burden

2. Rise in Demand for Blood Components and Associated Safety

3. Technological Advancement in Development of New Apheresis Techniques

4. Rise in the Reimbursement Policies and Funding for Apheresis Procedures

3. APHERESIS Market Restraints

1. High Capital Investment and Cost Associated with Apheresis Procedures

2. Lack of Qualified Skilled Professionals

3. Risk of Blood Contamination

4. Porter's Five Force Analysis

1. Threat of New Entrants

2. Bargaining Power of Buyers/Consumers

3. Bargaining Power of Suppliers

4. Threat of Substitute Products

5. Intensity of Competitive Rivalry


1. By Product

1. Devices

2. Disposables

3. Interventional/Surgical Simulators

2. By Apheresis Procedure

1. Leukapheresis

2. Plasmapheresis

3. Plateletpheresis

4. Erythrocytapheresis

5. Other Apheresis Procedures

3. By Technology

1. Centrifugation

2. Membrane Separation

4. By Application

1. Renal Disorders

2. Hematological Disorders

3. Neurological Disorders

4. Autoimmune Disorders

5. Other Applications

5. By Geography

1. North America

1. US

2. Canada

3. Mexico

2. Europe

1. Germany

2. UK

3. France

4. Italy

5. Spain

6. Rest of Europe

3. Asia Pacific

1. China

2. Japan

3. India

4. Australia

5. South Korea

6. Rest of Asia-Pacific

4. Middle East and Africa

1. GCC

2. South Africa

3. Rest of Middle East and Africa

5. Latin America

1. Brazil

2. Argentina

3. Rest of Latin America


1. Company Profiles

1. Asahi Kasei Corporation

2. B. Braun Melsungen AG

3. Cerus Corporation

4. Fresenius SE & Co. KGaA

5. Haemonetics Corporation

6. HemaCare Corporation

7. Kaneka Corporation

8. Kawasumi Laboratories Inc.

9. Terumo Corporation

10. Therakos Inc.

*List Not Exhaustive


Purchase this Market Research Report


Call us on : +1 888 709 8757

Drop us an email at :